"The U.S. Food and Drug Administration today approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy (treatment-naïve)."
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm256087.htm